每經AI快(kuai)訊(xun)，塞力醫(yi)療1月17日晚間發布(bu)業績預(yu)告，公(gong)(gong)司(si)(si)預(yu)計2024年度實現歸屬于(yu)(yu)上市(shi)公(gong)(gong)司(si)(si)股(gu)(gu)(gu)東的凈(jing)利(li)(li)潤為-2.1億元(yuan)人(ren)民(min)幣到-2.5億元(yuan)人(ren)民(min)幣，同比虧(kui)損(sun)增加5143萬元(yuan)人(ren)民(min)幣到9143萬元(yuan)人(ren)民(min)幣；業績變動主要原(yuan)因是(shi)，轉(zhuan)讓(rang)控(kong)股(gu)(gu)(gu)子公(gong)(gong)司(si)(si)導致(zhi)(zhi)利(li)(li)潤下降。為契(qi)合(he)公(gong)(gong)司(si)(si)整體戰(zhan)略規劃，提升資產運(yun)營及使用(yong)效率，優化財務(wu)狀況，公(gong)(gong)司(si)(si)于(yu)(yu)2024年9月轉(zhuan)讓(rang)公(gong)(gong)司(si)(si)持有(you)(you)(you)(you)的控(kong)股(gu)(gu)(gu)子公(gong)(gong)司(si)(si)武漢匯信(xin)科(ke)技發展有(you)(you)(you)(you)限責任公(gong)(gong)司(si)(si)80%股(gu)(gu)(gu)權、2024年10月轉(zhuan)讓(rang)公(gong)(gong)司(si)(si)持有(you)(you)(you)(you)的控(kong)股(gu)(gu)(gu)子公(gong)(gong)司(si)(si)阿克(ke)蘇(su)詠林瑞福電子科(ke)技有(you)(you)(you)(you)限公(gong)(gong)司(si)(si)51%股(gu)(gu)(gu)權，轉(zhuan)讓(rang)控(kong)股(gu)(gu)(gu)子公(gong)(gong)司(si)(si)股(gu)(gu)(gu)權合(he)計產生虧(kui)損(sun)約6000萬元(yuan)。同時，被(bei)轉(zhuan)讓(rang)子公(gong)(gong)司(si)(si)自轉(zhuan)讓(rang)之日起不再納入公(gong)(gong)司(si)(si)合(he)并報(bao)表范(fan)圍，導致(zhi)(zhi)利(li)(li)潤進一(yi)步下降。

塞力醫療(liao)的董事長(chang)是溫(wen)偉(wei)，男，55歲，學歷背景(jing)為本科；總經理是王政，男，57歲，學歷背景(jing)為碩士(shi)。

每經頭條（nbdtoutiao）——

(記者 王曉波)

免責聲(sheng)明：本文內容與(yu)數據僅供參考(kao)，不(bu)構成(cheng)投資(zi)建議，使(shi)用前請核(he)實。據此操作(zuo)，風險自(zi)擔。